MYSM1/miR-150/FLT3 inhibits B1a cell proliferation
Xiaoxia Jiang(Hangzhou Women’s Hospital), Guang Yang(Liaoning Technical University), Fengjun Xiao(Beijing Research Institute of Mechanical and Electrical Technology), Zhanguo Li(Shandong University of Science and Technology), Rong Mu(China Pharmaceutical University), Yu Liu(University of Macau), Yaping Gao(Beijing Institute of Education), Bing Shen(Institute of Basic Medical Sciences of the Chinese Academy of Medical Sciences), Bing Liu(Peking University Shenzhen Hospital), Hong Li(Wuhan University), Jing Zhang(Peking University), Jianping Guo(Beihua University), Si–Yi Chen(University of Southern California), Yanmei Yang(Thomas Jefferson University), Changyong Wang(Guilin Medical University)
Cited by 12
Related Papers
Cloning and Functional Expression of the Human Histamine H<sub>3</sub>Receptor
|Molecular Pharmacology|1999|700
A protocol for isolation and culture of mesenchymal stem cells from mouse compact bone
|Nature Protocols|2010|651
Low-dose interleukin-2 treatment selectively modulates CD4+ T cell subsets in patients with systemic lupus erythematosus
|Nature Medicine|2016|570
Scavenger receptor-A is a biomarker and effector of rheumatoid arthritis: A large-scale multicenter study
|Nature Communications|2020|420
Cloning and Pharmacological Characterization of a Fourth Histamine Receptor (H<sub>4</sub>) Expressed in Bone Marrow
|Molecular Pharmacology|2001|408